Vivaldi Coelho Rogerio
Insider CIK 1610381 · NERV President and CEO, Director · ONCE Chief Commercial Officer · CRNX Director · BIVV EVP, Chief Global Therapeutics · VTRS Director · SGTX President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 8,750 | $66.71 | $583.7K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 35,000 | $56.69 | $1.98M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 13,300 | $85.00 | $1.13M | 5,925 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 9,730 | $49.13 | $478.0K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 10,350 | $52.67 | $545.1K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 12,500 | $40.29 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 17,500 | $64.68 | $1.13M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 8,750 | $66.71 | $583.7K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer deriv | 2026-09-01 | 2026-09-01 | 35,000 | $56.69 | $1.98M | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 5,925 | $85.00 | $503.6K | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | D To issuer | 2026-09-01 | 2026-09-01 | 13,300 | $85.00 | $1.13M | 5,925 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-07-02 | 2026-07-07 | 3,000 | $40.00 | $120.0K | 19,225 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2026-06-18 | 2026-06-22 | 9,730 | — | $0 | 9,730 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-06-18 | 2026-06-22 | 5,925 | — | $0 | 22,225 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-03-12 | 2026-03-13 | 523 | $36.77 | $19.2K | 16,300 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-03-12 | 2026-03-13 | 4,477 | $36.08 | $161.5K | 16,823 | SEC↗ |
| VTRS Viatris Inc | M Exercise deriv | 2026-03-06 | 2026-03-10 | 23,660 | — | $0 | 0 | SEC↗ |
| VTRS Viatris Inc | M Exercise deriv | 2026-03-06 | 2026-03-10 | 1,174 | — | $0 | 0 | SEC↗ |
| VTRS Viatris Inc | A Award deriv | 2026-03-06 | 2026-03-10 | 15,890 | — | $0 | 15,890 | SEC↗ |
| VTRS Viatris Inc | M Exercise | 2026-03-06 | 2026-03-10 | 23,660 | — | $0 | 45,351 | SEC↗ |
| VTRS Viatris Inc | M Exercise | 2026-03-06 | 2026-03-10 | 1,175 | — | $0 | 46,526 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2025-06-11 | 2025-06-13 | 10,350 | — | $0 | 10,350 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2025-06-11 | 2025-06-13 | 6,900 | — | $0 | 21,300 | SEC↗ |
| VTRS Viatris Inc | A Award deriv | 2025-03-06 | 2025-03-10 | 23,660 | — | $0 | 23,660 | SEC↗ |
| VTRS Viatris Inc | M Exercise deriv | 2025-03-04 | 2025-03-05 | 423 | — | $0 | 0 | SEC↗ |
| VTRS Viatris Inc | M Exercise deriv | 2025-03-04 | 2025-03-05 | 21,267 | — | $0 | 0 | SEC↗ |
| VTRS Viatris Inc | M Exercise | 2025-03-04 | 2025-03-05 | 21,267 | — | $0 | 21,267 | SEC↗ |
| VTRS Viatris Inc | M Exercise | 2025-03-04 | 2025-03-05 | 424 | — | $0 | 21,691 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2024-06-07 | 2024-06-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2024-06-07 | 2024-06-11 | 3,400 | — | $0 | 14,400 | SEC↗ |
| VTRS Viatris Inc | A Award deriv | 2024-06-03 | 2024-06-04 | 21,267 | — | $0 | 21,267 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 35,382 | $0.75 | $26.5K | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer | 2023-08-11 | 2023-08-11 | 12,169 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | M Exercise deriv | 2023-07-21 | 2023-07-24 | 5,528 | — | $0 | 12,163 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | M Exercise | 2023-07-21 | 2023-07-24 | 5,528 | $19.24 | $106.4K | 11,963 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2023-06-16 | 2023-06-21 | 17,500 | — | $0 | 17,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2023-06-16 | 2023-06-21 | 6,000 | — | $0 | 11,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2023-06-08 | 2023-06-09 | 5,000 | $22.06 | $110.3K | 5,000 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2023-02-28 | 2023-03-01 | 460,000 | — | $0 | 460,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-06-17 | 2022-06-21 | 8,750 | — | $0 | 8,750 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2022-02-18 | 2022-02-22 | 230,000 | $1.48 | $340.4K | 230,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-01-03 | 2022-04-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-04 | 400,000 | $3.03 | $1.21M | 400,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-01-03 | 2022-01-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award | 2021-11-04 | 2021-11-05 | 50,000 | — | $0 | 73,461 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2021-02-11 | 2021-02-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 22,222 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion | 2020-12-08 | 2020-12-10 | 22,222 | — | $0 | 22,222 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 56,615 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 113,230 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 42,727 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer deriv | 2018-03-08 | 2018-03-08 | 14,230 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | D To issuer | 2018-03-08 | 2018-03-08 | 5,758 | — | $0 | 0 | SEC↗ |
| BIVV Bioverativ Inc. | M Exercise deriv | 2018-02-14 | 2018-02-15 | 7,114 | — | $0 | 14,230 | SEC↗ |
| BIVV Bioverativ Inc. | M Exercise | 2018-02-14 | 2018-02-15 | 7,114 | — | $0 | 7,429 | SEC↗ |
| BIVV Bioverativ Inc. | F Tax w/h | 2018-02-14 | 2018-02-15 | 2,126 | $103.52 | $220.1K | 5,303 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2018-01-31 | 2018-02-02 | 42,727 | — | $0 | 42,727 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-02-16 | 56,514 | — | $0 | 56,514 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-02-16 | 113,028 | — | $0 | 113,028 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-02-16 | 21,344 | — | $0 | 21,344 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-03-27 | 56,615 | — | $0 | 56,615 | SEC↗ |
| BIVV Bioverativ Inc. | A Award deriv | 2017-02-14 | 2017-03-27 | 113,230 | — | $0 | 113,230 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2016-07-15 | 2016-07-19 | 1,000 | — | $0 | 10,203 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2016-07-15 | 2016-07-19 | 5,000 | — | $0 | 155,186 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2016-07-15 | 2016-07-19 | 1,000 | — | $0 | 9,116 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2016-07-15 | 2016-07-19 | 5,000 | $7.50 | $37.5K | 25,716 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-07-15 | 2016-07-19 | 5,600 | $52.96 | $296.6K | 20,116 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-07-15 | 2016-07-19 | 1,400 | $53.32 | $74.6K | 18,716 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2016-07-15 | 2016-07-19 | 1,000 | $3.45 | $3.5K | 20,716 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2016-07-15 | 2016-07-19 | 1,000 | $3.45 | $3.5K | 19,716 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2016-04-21 | 2016-04-22 | 200 | — | $0 | 160,186 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2016-04-21 | 2016-04-22 | 1,000 | — | $0 | 10,116 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2016-04-21 | 2016-04-22 | 1,000 | $3.45 | $3.5K | 19,716 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-04-21 | 2016-04-22 | 1,200 | $40.02 | $48.0K | 18,716 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2016-04-21 | 2016-04-22 | 200 | $7.50 | $1.5K | 19,916 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2016-04-20 | 2016-04-22 | 1,000 | — | $0 | 11,203 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2016-04-20 | 2016-04-22 | 4,800 | — | $0 | 160,386 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2016-04-20 | 2016-04-22 | 5,800 | $40.02 | $232.1K | 18,716 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2016-04-20 | 2016-04-22 | 4,800 | $7.50 | $36.0K | 24,516 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2016-04-20 | 2016-04-22 | 1,000 | $3.45 | $3.5K | 19,716 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2016-01-05 | 2016-01-07 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2015-10-13 | 2015-10-14 | 37,333 | — | $0 | 165,186 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2015-10-13 | 2015-10-14 | 37,333 | $7.50 | $280.0K | 42,716 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-10-13 | 2015-10-14 | 24,000 | $48.15 | $1.16M | 18,716 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2015-10-07 | 2015-10-09 | 5,000 | — | $0 | 12,203 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2015-10-07 | 2015-10-09 | 5,000 | — | $0 | 11,116 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2015-10-07 | 2015-10-09 | 30,000 | — | $0 | 202,519 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-10-07 | 2015-10-09 | 40,000 | $48.81 | $1.95M | 6,383 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | S Sale | 2015-10-07 | 2015-10-09 | 1,000 | $50.40 | $50.4K | 5,383 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2015-10-07 | 2015-10-09 | 30,000 | $7.50 | $225.0K | 46,383 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2015-10-07 | 2015-10-09 | 10,000 | $3.45 | $34.5K | 16,383 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | P Buy | 2015-02-04 | 2015-02-06 | 2,500 | $23.00 | $57.5K | 6,383 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2014-07-01 | 2014-07-09 | 41,667 | $6.00 | $250.0K | 41,667 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2014-06-30 | 2014-07-09 | 498,621 | — | $0 | 498,621 | SEC↗ |